- Home
- ORIC vs MAX Comparison
ORIC vs MAX Comparison
Compare ORIC & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- MAX
- Stock Information
- Founded
- ORIC 2014
- MAX 2014
- Country
- ORIC United States
- MAX United States
- Employees
- ORIC N/A
- MAX N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- MAX Industrial Machinery/Components
- Sector
- ORIC Health Care
- MAX Industrials
- Exchange
- ORIC Nasdaq
- MAX Nasdaq
- Market Cap
- ORIC 362.9M
- MAX 582.4M
- IPO Year
- ORIC 2020
- MAX 2020
- Fundamental
- Price
- ORIC $11.10
- MAX $10.35
- Analyst Decision
- ORIC Strong Buy
- MAX Strong Buy
- Analyst Count
- ORIC 9
- MAX 6
- Target Price
- ORIC $18.29
- MAX $17.92
- AVG Volume (30 Days)
- ORIC 949.2K
- MAX 405.8K
- Earning Date
- ORIC 08-11-2025
- MAX 07-30-2025
- Dividend Yield
- ORIC N/A
- MAX N/A
- EPS Growth
- ORIC N/A
- MAX N/A
- EPS
- ORIC N/A
- MAX 0.28
- Revenue
- ORIC N/A
- MAX $1,002,364,000.00
- Revenue This Year
- ORIC N/A
- MAX $24.09
- Revenue Next Year
- ORIC N/A
- MAX $11.18
- P/E Ratio
- ORIC N/A
- MAX $37.20
- Revenue Growth
- ORIC N/A
- MAX 148.62
- 52 Week Low
- ORIC $3.90
- MAX $7.33
- 52 Week High
- ORIC $14.67
- MAX $20.91
- Technical
- Relative Strength Index (RSI)
- ORIC 66.82
- MAX 45.90
- Support Level
- ORIC $10.42
- MAX $10.05
- Resistance Level
- ORIC $11.50
- MAX $11.14
- Average True Range (ATR)
- ORIC 0.62
- MAX 0.37
- MACD
- ORIC -0.03
- MAX -0.07
- Stochastic Oscillator
- ORIC 83.30
- MAX 26.43
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.